Buti M - Search Results

1

Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.

Reijnders JG, Deterding K, Petersen J, Zoulim F, Santantonio T, Buti M, van Bömmel F, Hansen BE, Wedemeyer H, Janssen HL; VIRGIL Surveillance Study Group. Reijnders JG, et al. Among authors: buti m. J Hepatol. 2010 Apr;52(4):493-500. doi: 10.1016/j.jhep.2010.01.012. Epub 2010 Feb 4. J Hepatol. 2010. PMID: 20185191 Clinical Trial.

2

Chronic hepatitis D in intravenous drug addicts and non-addicts. A comparative clinico-pathological study.

Buti M, Mas A, Sánchez-Tapias JM, Esteban R, Bruguera M, Allende H, Costa J, Guardia J, Rodés J. Buti M, et al. J Hepatol. 1988 Oct;7(2):169-74. doi: 10.1016/s0168-8278(88)80479-3. J Hepatol. 1988. PMID: 3192921

3

The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection.

Jardi R, Buti M, Rodriguez-Frias F, Cortina M, Esteban R, Guardia J, Pascual C. Jardi R, et al. Among authors: buti m. J Hepatol. 1996 Jun;24(6):680-5. doi: 10.1016/s0168-8278(96)80263-7. J Hepatol. 1996. PMID: 8835742

4

Transient emergence of hepatitis B variants in a patient with chronic hepatitis B resistant to lamivudine.

Buti M, Jardi R, Cotrina M, Rodriguez-Frias F, Esteban R, Guardia J. Buti M, et al. J Hepatol. 1998 Mar;28(3):510-3. doi: 10.1016/s0168-8278(98)80327-9. J Hepatol. 1998. PMID: 9551691

5

Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C.

Buti M, Casado MA, Fosbrook L, Wong JB, Esteban R. Buti M, et al. J Hepatol. 2000 Oct;33(4):651-8. doi: 10.1034/j.1600-0641.2000.033004651.x. J Hepatol. 2000. PMID: 11059872

6

A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation.

Buti M, Mas A, Prieto M, Casafont F, González A, Miras M, Herrero JI, Jardí R, Cruz de Castro E, García-Rey C. Buti M, et al. J Hepatol. 2003 Jun;38(6):811-7. doi: 10.1016/s0168-8278(03)00087-4. J Hepatol. 2003. PMID: 12763375 Clinical Trial.

7

Current therapies for chronic hepatitis B.

Buti M. Buti M. Ann Hepatol. 2003 Jul-Sep;2(3):108-12. Ann Hepatol. 2003. PMID: 15115961 Free article. Review. No abstract available.

8

Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C.

Buti M, San Miguel R, Brosa M, Cabasés JM, Medina M, Angel Casado M, Fosbrook L, Esteban R. Buti M, et al. J Hepatol. 2005 May;42(5):639-45. doi: 10.1016/j.jhep.2004.12.031. J Hepatol. 2005. PMID: 15826711

9

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia.

Zeuzem S, Buti M, Ferenci P, Sperl J, Horsmans Y, Cianciara J, Ibranyi E, Weiland O, Noviello S, Brass C, Albrecht J. Zeuzem S, et al. Among authors: buti m. J Hepatol. 2006 Jan;44(1):97-103. doi: 10.1016/j.jhep.2005.10.003. Epub 2005 Nov 7. J Hepatol. 2006. PMID: 16290907 Clinical Trial.

10

Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients.

Buti M, Elefsiniotis I, Jardi R, Vargas V, Rodriguez-Frias F, Schapper M, Bonovas S, Esteban R. Buti M, et al. J Hepatol. 2007 Sep;47(3):366-72. doi: 10.1016/j.jhep.2007.04.011. Epub 2007 May 24. J Hepatol. 2007. PMID: 17561304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

656 results

Search Page

Filters